Next Hydrogen Solutions Inc. — Regulatory Filings 2021

Mar 22, 2021

OFFICER’S CERTIFICATE

TO: Alberta Securities Commission Autorité des marches financiers British Columbia Securities Commission Financial and Consumer Affairs Authority of Saskatchewan, Securities Division Manitoba Securities Commission Ontario Securities Commission

RE: Annual General and Special Meeting of the Shareholders of BioHep Technologies Ltd. (the “Corporation”) to be held on April 12, 2021 (the “Meeting”)

______________________________________________________________________________

With reference to National Instrument 54-101 ― Communication with Beneficial Owners of Securities of a Reporting Issuer (“ NI 54-101 ”), the undersigned, Donald Gordon, Chief Financial Officer of the Corporation, in such capacity and not in his personal capacity, certifies for and on behalf of the Corporation, that:

1. in accordance with the requirements set out in section 2.20(a) of NI 54-101, arrangements have been made to have the proxy-related materials for the Meeting sent in compliance with the applicable timing requirements in sections 2.9 and 2.12 of NI 54-101;

2. in accordance with the requirements set out in section 2.20(b) of NI 54-101, arrangements have been made to carry out all of the requirements of NI 54-101 in addition to those described in paragraph 1 above; and

3. the Corporation is relying upon section 2.20 of NI 54-101 in connection with the Meeting.

DATED as of the 22[nd] day of March, 2021.

BIOHEP TECHNOLOGIES LTD.

Per: “Donald Gordon” Name: Donald Gordon Title: Chief Financial Officer

Certificate of Abridgement